Regeneron Pharmaceuticals (REGN) Other Working Capital Changes (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly Other Working Capital Changes of $43.9 million for Q2 2026, up 130.72% year-over-year from $19.0 million in Q2 2025, and down 55.92% quarter-over-quarter from $99.6 million in Q1 2026.
Regeneron Pharmaceuticals (REGN) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $43.9 million for Q2 2026.
- In Q2 2026, Other Working Capital Changes rose 130.72% year-over-year to $43.9 million; the TTM figure through Jun 2026 stood at $217.0 million (up 309.86% YoY), while the FY2025 annual figure was -$51.7 million, down 122.7% from the prior year.
- Other Working Capital Changes for Q2 2026 stood at $43.9 million, down from $99.6 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $526.3 million in Q2 2024, with the low at -$252.0 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is $51.6 million (2024), against an average of $87.2 million.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes plunged 477.89% in 2023, then jumped 714.48% in 2024.
- Regeneron Pharmaceuticals' Other Working Capital Changes stood at -$59.6 million in 2022, then jumped by 172.15% to $43.0 million in 2023, then slumped by 149.3% to -$21.2 million in 2024, then surged by 85.38% to -$3.1 million in 2025, then surged by 1516.13% to $43.9 million in 2026.
- Business Quant data shows REGN's Other Working Capital Changes at $43.9 million in Q2 2026, $99.6 million in Q1 2026, and -$3.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 319.10 Mn |
| Jun 30, 2026 | 319.10 Mn |
| Jun 30, 2026 | 319.10 Mn |
| Mar 31, 2026 | 198.60 Mn |
| Mar 31, 2026 | 198.60 Mn |
| Mar 31, 2026 | 198.60 Mn |
| Dec 31, 2025 | -82.80 Mn |
| Dec 31, 2025 | -82.80 Mn |
| Dec 31, 2025 | -82.80 Mn |
| Sep 30, 2025 | 47.90 Mn |
| Sep 30, 2025 | 47.90 Mn |
| Sep 30, 2025 | 47.90 Mn |
| Jun 30, 2025 | 230.70 Mn |
| Jun 30, 2025 | 230.70 Mn |
| Jun 30, 2025 | 230.70 Mn |
| Mar 31, 2025 | 179.50 Mn |
| Mar 31, 2025 | 179.50 Mn |
| Mar 31, 2025 | 179.50 Mn |
| Dec 31, 2024 | 55.30 Mn |
| Dec 31, 2024 | 55.30 Mn |